15 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
15 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
15 DaysReady to play
Ready to play
A new study has shown that an experimental treatment based on genetic optics science can potentially improve vision functions in patients with advanced retinitis pigmentosa. This is achieved mainly by introducing a gene that produces a light-sensitive protein called "Crimson-AR" into modified retinal cells. The treatment resulted in improved light sensitivity in 7 out of 10 participants, with some able to accurately recognize and reach objects. Additionally, visual signals were confirmed to reach the brain through electroencephalogram (EEG) recordings. The study suggests that this approach could effectively help patients with inherited blindness and is an important step toward restoring vision regardless of the underlying genetic mutation.
Notice: This Is an AI-Generated Summary
Comments (0)